Philip J. Vickers
CIK 1635046 · last filed 2026-04-03
Philip J. Vickers is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for AKBA, was dated Apr 3, 2026. Across all open-market trades the lifetime net is +$138.5K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
19
$138.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKBA | Director | — | $0.92 | — | $0 | 1 | 2026-04-03 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | 4,800 | $16.80 | $80.6K | $40.1K | 7 | 2023-06-08 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 29,722 | $3.65 | $108.5K | $98.4K | 11 | 2022-05-13 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | AKBA | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,059 | $0 | EDGAR |
| 2021-07-08 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Buy (P) | +4,800 | $40.1K | EDGAR |
| 2021-06-14 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +4,013 | $0 | EDGAR |
| 2020-06-05 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,000 | $0 | EDGAR |